Tsveta Milanova
Chief Commercial Officer at Agios Pharmaceuticals, Inc. (AGIO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $353K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 6SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 3,26246,829 held (−7%) | $34.71 | $113K | -8.4% |
| Mar 3SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 1,68138,778 held (−4%) | $28.96 | $49K | +9.8% |
| Mar 3SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 1,18741,591 held (−3%) | $28.96 | $34K | +9.8% |
| Jan 7SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 2,87234,793 held (−8%) | $27.02 | $78K | +17.7% |
| Jan 2SEC | AGIOAgios Pharmaceuticals, Inc. | Sell Plan | 2,93229,190 held (−9%) | $27.09 | $79K | +17.4% |
- Sell
Chief Commercial Officer Tsveta Milanova sold $113K of AGIO at $34.71 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Tsveta Milanova sold $49K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Tsveta Milanova sold $34K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Tsveta Milanova sold $78K of AGIO at $27.02 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Tsveta Milanova sold $79K of AGIO at $27.09 — pre-scheduled 10b5-1 plan sale.